Dr. Reddy's Laboratories Limited

NSE: DRREDDY

Pharma Pharmaceuticals

₹1,242.5

+0.77%EOD · 19 Oct

Dr. Reddy's Laboratories Limited is a listed Pharmaceuticals company on NSE/BSE. Detailed profile data is being compiled — check BSE filings for the latest disclosures.

Market Cap

₹1.03 L Cr

52W Range

₹1415 / ₹1101

Volume

1024K

47.8% delivery

1Y Return

+0.8%

P/E Ratio

31.0

P/B Ratio

2.7

ROE

8.8%

Debt / Equity

18.61

Peers in Pharma

Top 8 by market cap

Company	LTP	Market Cap	P/E	P/B	ROE %	Div Yld %
Dr. Reddy's Laboratories Limited(this stock)	₹1,242.5	₹1.03 L Cr	31.0	2.7	8.8%	0.66%
Sun Pharmaceutical Industries LimitedSUNPHARMA	₹1,743	₹4.18 L Cr	34.9	5.0	14.7%	0.91%
Cipla LimitedCIPLA	₹1,324.1	₹1.07 L Cr	31.8	3.1	11.7%	0.98%
Lupin LimitedLUPIN	₹1,939.2	₹88,678 Cr	16.3	4.0	26.9%	0.91%

Quality Score

Durability · Valuation · Momentum — objective math, not advice

45/100

Composite score: 40% quality, 30% valuation, 30% momentum

QualityWeak · 35

ValuationGood · 58

MomentumAverage · 45

High debt load (D/E 18.6)

In confirmed downtrend (Stage 4)

Technical Indicators

Full analysis · objective math, not advice

Returns

+0.8%

+1.1%

+4.9%

+5.0%

+2.1%

+0.8%

Weinstein Stage

Stage 4 — Declining (downtrend)

RSI (14)

48 Neutral

Trend Template

2/7weak

RS vs Nifty (3M)

+11.0pp

Moving Averages (price vs MA)

20-DMA

₹1216

above

50-DMA

₹1190

above

150-DMA

₹1240

above

200-DMA

₹1244

below

From 52W High

-12.2%

From 52W Low

+12.9%

Support (20D)

₹1167

Resistance (20D)

₹1253

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

Quality Signals

Multi-year consistency · Source: Screener annual data

ROE Consistency

0/0 years ≥15%

Revenue Growth

+6.7% CAGR

Up 8 of last 11 years

Earnings Quality

Fully cash-backed

OCF / Net Profit = 1.45x · 12/12 yrs +ve cash flow

Quality signals derived from multi-year annual financials. ROE consistency = years with ≥15% return on equity. Cash-backed = operating cash flow vs reported net profit (≥1x means earnings are converted to real cash, not just accruals). Educational reference only — not investment advice.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

No comments yet — be the first to share your view.